Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection.
- Resource Type
- Article
- Source
- AIDS Research & Human Retroviruses; Jan2020, Vol. 36 Issue 1, p13-18, 6p
- Subject
- Language
- ISSN
- 08892229